Obermatt
See Similar Stocks →

Flags

Financial distress

Enovis

NYQ:ENOV · US1940145022
Health Care Equipment & SuppliesLarge

360

40
Profit price53
Owner Earnings Yield1
Dividend Yield1
Price/Sales91
EV / Gross Profit91
Price/Book82
Return on Capital45
Cash Return on Capital18
Return on Equity15
EBIT Margin44
Gross Profitability54
Accruals95
Owner Earnings Margin16
Sales growth33
Profit Growth29
Long-Term EPS Growth18
Reinvestment43
Price momentum36
Debt load26
Refinancing98
Debt Payback1
Liquidity50
Analyst ratings64
Opinion Changes86
Price Target Upside94
Market mood31
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Enovis doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeNYSE
Founded1998
Employees1,811
Websiteenovis.com
ISINUS1940145022
Last UpdateApr 2, 2026
Indices
D.J. US Medical Equipment
Themes
Pain ManagementBiomedical EngineeringWellness and RecoveryOrthopaedicsSurgeryIndustrialManufacturingOil and Gas

Description

Enovis Corporation (Enovis) is a medical technology company. The company is focused on developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows by manufacturing, and distributing high-qu…

Analysis

Middle-of-the-road

Enovis Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 6/20 on our value-creation score: not creating value. Analysts lean positive.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
85
2023202420252026

All-time high

100

Feb 2024

All-time low

78

Jan 2023

Average rank

90

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
91
82
72
97
Price/Earnings
51
81
57
100
Price/Book
82
89
86
100
Dividend Yield
1
1
1
1
Value (overall)
84
87
77
99

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Enovis with its peers
Sight Sciences
NSQ:SGHT
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
SI-BONE
NMQ:SIBN
33
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Stryker
NYQ:SYK
60
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Globus Medical
NYQ:GMED
98
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Glaukos
NYQ:GKOS
31
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →